[go: up one dir, main page]

NO942228D0 - Ipsapiron-legemiddeltilberedning - Google Patents

Ipsapiron-legemiddeltilberedning

Info

Publication number
NO942228D0
NO942228D0 NO942228A NO942228A NO942228D0 NO 942228 D0 NO942228 D0 NO 942228D0 NO 942228 A NO942228 A NO 942228A NO 942228 A NO942228 A NO 942228A NO 942228 D0 NO942228 D0 NO 942228D0
Authority
NO
Norway
Prior art keywords
ipsapirone
drug preparation
drug
preparation
ipsapirone drug
Prior art date
Application number
NO942228A
Other languages
English (en)
Other versions
NO942228L (no
Inventor
Peter Serno
Wolfgang Fischer
Roland Rupp
Mark Versavel
Ulrich Tenter
Gerhard Schmidt
Gunter Schollnhammer
Maria Ammen
Shinji Maegata
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO942228D0 publication Critical patent/NO942228D0/no
Publication of NO942228L publication Critical patent/NO942228L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942228A 1993-06-15 1994-06-14 Ipsapiron-legemiddeltilberedning NO942228L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4319760A DE4319760A1 (de) 1993-06-15 1993-06-15 Ipsapiron Arzneimittelzubereitung

Publications (2)

Publication Number Publication Date
NO942228D0 true NO942228D0 (no) 1994-06-14
NO942228L NO942228L (no) 1994-12-16

Family

ID=6490360

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942228A NO942228L (no) 1993-06-15 1994-06-14 Ipsapiron-legemiddeltilberedning

Country Status (16)

Country Link
EP (1) EP0629402A1 (no)
JP (1) JPH06345649A (no)
KR (1) KR950000150A (no)
CN (1) CN1099263A (no)
AU (1) AU6345794A (no)
CA (1) CA2125620A1 (no)
CZ (1) CZ146494A3 (no)
DE (1) DE4319760A1 (no)
FI (1) FI942803A7 (no)
HU (1) HUT70759A (no)
IL (1) IL109993A0 (no)
NO (1) NO942228L (no)
NZ (1) NZ260732A (no)
PL (1) PL303822A1 (no)
SK (1) SK72494A3 (no)
ZA (1) ZA944187B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
EP1140105B1 (en) * 1998-12-24 2003-10-22 Janssen Pharmaceutica N.V. Controlled release galantamine composition
WO2004103338A1 (en) * 2003-05-19 2004-12-02 Bioprogress Plc Adhesives and film modifying compositions
EP4062913B1 (en) * 2020-09-02 2024-05-08 Beijing Biostar Pharmaceuticals Co., Ltd. Solid oral formulation of utidelone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0386440T3 (da) * 1989-02-11 1992-09-14 Bayer Ag Lægemidler med kontrolleret afgivelse af virksomt stof
DD297767A5 (de) * 1990-03-06 1992-01-23 Bayer Aktiengesellschaft,De Arzneimittel mit kontrollierter wirkstoffabgabe
JPH04360826A (ja) * 1991-06-07 1992-12-14 Bayer Yakuhin Kk 放出制御製剤

Also Published As

Publication number Publication date
CN1099263A (zh) 1995-03-01
NZ260732A (en) 1996-02-27
KR950000150A (ko) 1995-01-03
IL109993A0 (en) 1994-10-07
FI942803L (fi) 1994-12-16
DE4319760A1 (de) 1994-12-22
ZA944187B (en) 1995-02-08
JPH06345649A (ja) 1994-12-20
FI942803A0 (fi) 1994-06-13
NO942228L (no) 1994-12-16
CZ146494A3 (en) 1995-01-18
EP0629402A1 (de) 1994-12-21
FI942803A7 (fi) 1994-12-16
SK72494A3 (en) 1995-04-12
PL303822A1 (en) 1995-01-09
HU9401771D0 (en) 1994-09-28
CA2125620A1 (en) 1994-12-16
HUT70759A (en) 1995-10-30
AU6345794A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
DK0515312T3 (da) Farmaceutisk præparat
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
DK0616523T3 (da) Lægemidler
DE69525148D1 (de) Pharmazeutische formulierung
ATA129892A (de) Pharmazeutische zusammensetzung
NO942923L (no) Medikamenter
NO923127L (no) Farmasoeytisk kombinasjonsformulering
FI971279L (fi) Lääkkeitä
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
FI930882A0 (fi) Farmaceutiska foereningar
FI924456A7 (fi) Lääke
DE4294862T1 (de) Pharmazeutische Komposition
FI931251A0 (fi) Farmaceutiska foereningar
FI951155L (fi) Farmaseuttinen valmiste
NO942228D0 (no) Ipsapiron-legemiddeltilberedning
FI921786A7 (fi) Farmaceutisk foerening
FI921785A7 (fi) Farmaceutisk foerening
FI950533L (fi) Seco-nukleosidien liponulkeotidit, niiden valmistaminen sekä niiden käyttö virusten vastaisina lääkkeinä
FI923869L (fi) Farmaceutiska aemnen
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
DK88093D0 (da) Stabilt praeparat
IT9048026A0 (it) Preparato farmaceutico e/o cosmetico.
SE9302429D0 (sv) New pharmaceutical preparation ii
NO933315D0 (no) Legemiddel
DK103393D0 (da) Praeparat